Novel Chiral Composite Membrane Prepared Via the Interfacial Polymerization of Diethylamino-Beta-cyclodextrin for the Enantioseparation of Chiral Drugs

Jian Ke,Ying Zhang,Xiaoyue Zhang,Yanhua Liu,Yibing Ji,Jianqiu Chen
DOI: https://doi.org/10.1016/j.memsci.2019.117635
IF: 9.5
2020-01-01
Journal of Membrane Science
Abstract:A novel chiral thin-film composite polyamide (CTFC) membrane was fabricated by using in situ interfacial polymerization. The diethylamino-beta-cyclodextrin (EDA-beta-CD) monomer was synthesized as the chiral selector and interfacially polymerized with trimesoyl chloride (TMC) to fabricate the CTFC membrane on the surface of a commercial cellulose acetate (CA) membrane. The intrinsic properties of the chiral EDA-beta-CD-TMC/CA membrane were investigated by attenuated total reflectance-Fourier transform infrared spectroscopy (ATR-FTIR), X-ray photoelectron spectroscopy (XPS) and scanning electron microscopy (SEM). Several parameters, namely, EDA-beta-CD concentration, interfacial polymerization (IP) time, and curing time were varied. At the optimal conditions, the water permeate flux was 35.7 L m(-2) h(-1) and the rejection of BSA was 80.7%. For the enantioseparation, various chiral drugs such as warfarin, ibuprofen, nefopam, ketopmfen and tryptophan were separated using chiral EDA-beta-CD-TMC/CA membranes. The results indicate that the percent enantiomeric excess (e.e%) was above 9.29 +/- 3.21% for warfarin, 3.77 +/- 0.23% for ibuprofen and 27.2% for tryptophan. Additionally, the as-prepared membrane was relatively stable in a wide pH range, so that it may be used for industrial production.
What problem does this paper attempt to address?